{"url":"https://lda.senate.gov/api/v1/filings/83cab83a-a495-4f27-a874-e28b31b09d0c/","filing_uuid":"83cab83a-a495-4f27-a874-e28b31b09d0c","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2025,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/83cab83a-a495-4f27-a874-e28b31b09d0c/print/","filing_document_content_type":"text/html","income":null,"expenses":"90000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brenna Leamer","dt_posted":"2026-01-14T20:46:17-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"901 F St., NW Suite 610","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":18411,"url":"https://lda.senate.gov/api/v1/registrants/18411/","house_registrant_id":31167,"name":"F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES","description":null,"address_1":"901 F St., NW Suite 610","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRENNA LEAMER","contact_telephone":"+1 317-282-3252","dt_updated":"2026-07-15T13:50:56.942960-04:00"},"client":{"id":123844,"url":"https://lda.senate.gov/api/v1/clients/123844/","client_id":12,"name":"F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-10"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Access to and reimbursement of diagnostics in the Medicare program. H.R. 5269 / S. 2761 Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare reimbursement of Clinical Laboratory Fee Schedule (CLFS), specifically reforms to address payment cuts resulting from the Protecting Access to Medicare Act (PAMA) 2014. S.1717 / H.R.5343 The Ensuring Patient Access to Critical Breakthrough Products Act. Issues related to Medicare coverage and reimbursement for FDA-designated breakthrough medical devices, focusing on establishing transitional coverage period Issues related to Tariffs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57673,"prefix":"mr","prefix_display":"MR.","first_name":"RUSSELL","nickname":null,"middle_name":"CONWELL","last_name":"RING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107364,"prefix":null,"prefix_display":null,"first_name":"BRENNA","nickname":null,"middle_name":"MARIE","last_name":"LEAMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82599,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"CARLTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144984,"prefix":null,"prefix_display":null,"first_name":"CASSANDRA","nickname":null,"middle_name":null,"last_name":"RICCI","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"FOR","general_issue_code_display":"Foreign Relations","description":"(FOR) HIV Testing in the President's Emergency Plan for AIDS Relief, including funding to support PEPFAR laboratory services and testing in FY2026 Appropriations for National Security, Department of State, and Related Programs, and PEPFAR Reauthorization in the FY2026 State Department Reauthorization (H.R.5300 - Department of State Policy Provisions Act)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107364,"prefix":null,"prefix_display":null,"first_name":"BRENNA","nickname":null,"middle_name":"MARIE","last_name":"LEAMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82599,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"CARLTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"(HCR) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Alzheimer's and Influenza Preparedness","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107364,"prefix":null,"prefix_display":null,"first_name":"BRENNA","nickname":null,"middle_name":"MARIE","last_name":"LEAMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57673,"prefix":"mr","prefix_display":"MR.","first_name":"RUSSELL","nickname":null,"middle_name":"CONWELL","last_name":"RING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82599,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"CARLTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144984,"prefix":null,"prefix_display":null,"first_name":"CASSANDRA","nickname":null,"middle_name":null,"last_name":"RICCI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"(MED) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Alzheimer's and Influenza Preparedness","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107364,"prefix":null,"prefix_display":null,"first_name":"BRENNA","nickname":null,"middle_name":"MARIE","last_name":"LEAMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57673,"prefix":"mr","prefix_display":"MR.","first_name":"RUSSELL","nickname":null,"middle_name":"CONWELL","last_name":"RING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82599,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"CARLTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144984,"prefix":null,"prefix_display":null,"first_name":"CASSANDRA","nickname":null,"middle_name":null,"last_name":"RICCI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}